Penserra Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Penserra Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-90,267	Closed	-$19.6M	–	1435
2021 Q1	$19.6M	Buy	90,267 +46,237	+105%	+$8.69M	0.36%	70
2020 Q4	$5.08M	Buy	44,030 +22,292	+103%	+$2.5M	0.12%	176
2020 Q3	$2.12M	Buy	21,738 +9,301	+75%	+$1.07M	0.08%	221
2020 Q2	$1.53M	Buy	12,437 +1,223	+11%	+$139K	0.08%	215
2020 Q1	$981K	Buy	11,214 +6,942	+163%	+$735K	0.07%	265
2019 Q4	$493K	Buy	4,272 +1,920	+82%	+$215K	0.03%	373
2019 Q3	$270K	Buy	+2,352	New	+$357K	0.02%	379

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Penserra Capital Management's GWPH Position: Q2 2021 in Review

Penserra Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 90,267 shares — an estimated $19.6M sold.

Penserra Capital Management first reported a position in GWPH in Q3 2019 and held it in 7 quarters. The position peaked at $19.6M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Penserra Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Penserra Capital Management sold 90,267 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $19.6M.
Penserra Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2019 and held it in 7 quarters.
Penserra Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $19.6M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Penserra Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.